Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Nathan

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
American Journal of Human Biology : the Official Journal of the Human Biology Council|November 24, 2021
Response to letter to the editor: Use natural logarithms not base 10 logarithms to compare group means (re: Increased thymus weight in sudden infant death syndrome compared tocontrols: The role of sub-clinical infections)Paul Nathan Goldwater, Igor A Kelmanson, Bert Little
JAMA Ophthalmology|December 4, 2025
Eye Safety Risks of Antibody-Drug Conjugate Cancer TherapiesPiotr K Kopinski, Paul Nathan, Mandeep S Sagoo
American Journal of Human Biology : the Official Journal of the Human Biology Council|October 27, 2020
Increased thymus weight in sudden infant death syndrome compared to controls: The role of sub-clinical infectionsPaul Nathan Goldwater, Igor A Kelmanson, Bertis B Little
European Journal of Cancer (Oxford, England : 1990)|March 24, 2022
Melanoma in pregnancy: Diagnosis and management in early-stage and advanced diseaseThomas J Carter, Christina George, Catherine Harwood, et al.
Journal for Immunotherapy of Cancer|October 6, 2020
Campylobacteriosis following immunosuppression for immune checkpoint inhibitor-related toxicityKarla A Lee, Heather Shaw, Véronique Bataille, et al.
British Journal of Hospital Medicine (London, England : 2005)|May 20, 2009
UK guidelines for the systemic treatment of renal cell carcinomaPaul Nathan, John Wagstaff, Emilio Porfiri, et al.
Dermatology (Basel, Switzerland)|May 14, 2016
What Is New in Melanoma Genetics and Treatment?Simone Ribero, Caterina Longo, Dan Glass, et al.
Melanoma Research|October 16, 2025
Surgical management of pulmonary metastases secondary to uveal melanoma: a case seriesMaria Comanici, Jan Lukas Robertus, Alexandra Rice, et al.
JAMA Oncology|September 24, 2020
Rationale for Immune Checkpoint Inhibitors Plus Targeted Therapy in Metastatic Melanoma: A ReviewReinhard Dummer, Paolo A Ascierto, Paul Nathan, et al.
Plos One|December 25, 2015
The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UKJames Larkin, Anthony J Hatswell, Paul Nathan, et al.
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
American Journal of Human Biology : the Official Journal of the Human Biology Council|November 24, 2021
Response to letter to the editor: Use natural logarithms not base 10 logarithms to compare group means (re: Increased thymus weight in sudden infant death syndrome compared tocontrols: The role of sub-clinical infections)Paul Nathan Goldwater, Igor A Kelmanson, Bert Little
JAMA Ophthalmology|December 4, 2025
Eye Safety Risks of Antibody-Drug Conjugate Cancer TherapiesPiotr K Kopinski, Paul Nathan, Mandeep S Sagoo
American Journal of Human Biology : the Official Journal of the Human Biology Council|October 27, 2020
Increased thymus weight in sudden infant death syndrome compared to controls: The role of sub-clinical infectionsPaul Nathan Goldwater, Igor A Kelmanson, Bertis B Little
European Journal of Cancer (Oxford, England : 1990)|March 24, 2022
Melanoma in pregnancy: Diagnosis and management in early-stage and advanced diseaseThomas J Carter, Christina George, Catherine Harwood, et al.
Journal for Immunotherapy of Cancer|October 6, 2020
Campylobacteriosis following immunosuppression for immune checkpoint inhibitor-related toxicityKarla A Lee, Heather Shaw, Véronique Bataille, et al.
British Journal of Hospital Medicine (London, England : 2005)|May 20, 2009
UK guidelines for the systemic treatment of renal cell carcinomaPaul Nathan, John Wagstaff, Emilio Porfiri, et al.
Dermatology (Basel, Switzerland)|May 14, 2016
What Is New in Melanoma Genetics and Treatment?Simone Ribero, Caterina Longo, Dan Glass, et al.
Melanoma Research|October 16, 2025
Surgical management of pulmonary metastases secondary to uveal melanoma: a case seriesMaria Comanici, Jan Lukas Robertus, Alexandra Rice, et al.
JAMA Oncology|September 24, 2020
Rationale for Immune Checkpoint Inhibitors Plus Targeted Therapy in Metastatic Melanoma: A ReviewReinhard Dummer, Paolo A Ascierto, Paul Nathan, et al.
Plos One|December 25, 2015
The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UKJames Larkin, Anthony J Hatswell, Paul Nathan, et al.
Pageof 13